Phantom-Based Validation and Optimization of NEOWAVE, an Innovative Cardiac Therapy Device
| Reference number | |
| Coordinator | CSW Therapeutics AB |
| Funding from Vinnova | SEK 500 000 |
| Project duration | November 2025 - July 2026 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovative Startups 2025 |
Important results from the project
The main goals were largely achieved. A functional tissue-mimicking phantom with embedded sensors was developed and used to assess acoustic fields, coupling, positioning, and thermal safety. Further optimization is needed for repeatable manufacturing and coupling detection. The project also strengthened international collaborations and contributed knowledge toward a potential patent.
Expected long term effects
The project provides a foundation for safer, more reliable testing, calibration, and continued development of NEOWAVE. The knowledge may also support future regulatory submissions, clinical applications, and other ultrasound or shockwave technologies.
Approach and implementation
The project covered requirements, prototype development, and testing. Technical and clinical experts supported the planning. Several design and casting iterations were required because sensor integration was more difficult than expected. Despite some delays, testing began within the project period, and collaboration with external partners worked well.